Spironolactone use and risk of incident cancers: a retrospective, matched cohort study

Aims Spironolactone is widely used to treat heart failure, hypertension and liver disease with increased usage in recent years. Spironolactone has endocrine effects that could influence cancer risks and historical reports suggest possible links with increased risk of certain types of cancer. The aim...

Full description

Saved in:

Bibliographic Details
Published in:	British journal of clinical pharmacology Vol. 83; no. 3; pp. 653 - 663
Main Authors:	Mackenzie, Isla S., Morant, Steven V., Wei, Li, Thompson, Alastair M., MacDonald, Thomas M.
Format:	Journal Article
Language:	English
Published:	England John Wiley and Sons Inc 01.03.2017
Subjects:	Adult Aged Aged, 80 and over cancer Case-Control Studies cohort study Female Humans Incidence Male Middle Aged Neoplasms - chemically induced Neoplasms - epidemiology Pharmacoepidemiology Proportional Hazards Models prostate Retrospective Studies Risk Factors spironolactone Spironolactone - adverse effects United Kingdom - epidemiology Young Adult cancer prostate cohort study spironolactone pharmacoepidemiology
ISSN:	0306-5251, 1365-2125, 1365-2125
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!